Effects of hydrogen peroxide mouthwash on preventing ventilator-associated pneumonia in patients admitted to the intensive care unit
- PMID: 27471125
- PMCID: PMC9425535
- DOI: 10.1016/j.bjid.2016.06.005
Effects of hydrogen peroxide mouthwash on preventing ventilator-associated pneumonia in patients admitted to the intensive care unit
Abstract
Aims: The aim of the study was to determine the effect of hydrogen peroxide (HP) mouthwash on the incidence of ventilator associated pneumonia (VAP) in patients admitted to the intensive care unit (ICU).
Methods: This was a randomized clinical trial conducted on 68 patients. The intervention group used 3% HP as mouthwash and the control group used mouthwashes with 0.9% normal saline (NS) twice a day. Data were collected using a questionnaire and the Modified Clinical Pulmonary Infection Score (MCPIS). MCPIS includes five items, body temperature: white blood cell count, pulmonary secretions, the ratio of pressure of arterial oxygen (PaO2) to fraction of inspired oxygen (FiO2), and the chest X-ray. Each of these items scored 0-2. Scores ≥6 were considered as VAP signs. The SPSS-20 software was employed to analyze the data.
Results: In total, 14.7% patients of the HP group and 38.2% patients of the NS group contracted VAP. The risk of VAP in the NS group was 2.60 times greater than that in the HP group (RR=2.60, 95% CI: 1.04-6.49, p=0.0279). The mean±SD MCPIS was calculated as 3.91±1.35 in the HP group and 4.65±1.55 in the NS group, a difference statistically significant (p=0.042). There were no significant differences in the risk factors for VAP between the two groups.
Conclusion: HP mouthwash was found more effective than NS in reducing VAP. HP mouthwash can therefore be used in routine nursing care for reducing VAP.
Keywords: Hydrogen peroxide; Intensive care unit; Nosocomial infection; Ventilator associated pneumonia.
Copyright © 2016 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. All rights reserved.
Similar articles
-
Effect of clove mouthwash on the incidence of ventilator-associated pneumonia in intensive care unit patients: a comparative randomized triple-blind clinical trial.Clin Oral Investig. 2023 Jul;27(7):3589-3600. doi: 10.1007/s00784-023-04972-w. Epub 2023 Mar 24. Clin Oral Investig. 2023. PMID: 36961592 Free PMC article. Clinical Trial.
-
Effect of propolis mouthwash on the incidence of ventilator-associated pneumonia in intensive care unit patients: a comparative randomized triple-blind clinical trial.BMC Oral Health. 2024 May 29;24(1):636. doi: 10.1186/s12903-024-04412-5. BMC Oral Health. 2024. PMID: 38811949 Free PMC article. Clinical Trial.
-
Evaluating the Efficacy of Nanosil Mouthwash on the Preventing Pulmonary Infection in Intensive Care Unit: a Randomized Clinical Trial.Med Arch. 2018 Jun;72(3):206-209. doi: 10.5455/medarh.2018.72.206-209. Med Arch. 2018. PMID: 30061768 Free PMC article. Clinical Trial.
-
Effect of different mouthwashes on ventilator-related outcomes and mortality in intensive care unit patients: A network meta-analysis.Aust Crit Care. 2025 Jan;38(1):101095. doi: 10.1016/j.aucc.2024.06.014. Epub 2024 Aug 23. Aust Crit Care. 2025. PMID: 39179488
-
Anti-Inflammatory and Anti-Bacterial Effects of Mouthwashes in Intensive Care Units: A Systematic Review and Meta-Analysis.Int J Environ Res Public Health. 2022 Dec 30;20(1):733. doi: 10.3390/ijerph20010733. Int J Environ Res Public Health. 2022. PMID: 36613055 Free PMC article.
Cited by
-
The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome.Front Med (Lausanne). 2021 Jun 4;8:671714. doi: 10.3389/fmed.2021.671714. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34150807 Free PMC article. Review.
-
Oral care medications for the prevention and treatment of ventilator-associated pneumonia in intensive care unit.Front Oral Health. 2025 Mar 18;6:1566355. doi: 10.3389/froh.2025.1566355. eCollection 2025. Front Oral Health. 2025. PMID: 40171055 Free PMC article. Review.
-
Effect of clove mouthwash on the incidence of ventilator-associated pneumonia in intensive care unit patients: a comparative randomized triple-blind clinical trial.Clin Oral Investig. 2023 Jul;27(7):3589-3600. doi: 10.1007/s00784-023-04972-w. Epub 2023 Mar 24. Clin Oral Investig. 2023. PMID: 36961592 Free PMC article. Clinical Trial.
-
The Use of Antibiotics for Ventilator-Associated Pneumonia in the MIMIC-IV Database.Front Pharmacol. 2022 Jun 13;13:869499. doi: 10.3389/fphar.2022.869499. eCollection 2022. Front Pharmacol. 2022. PMID: 35770093 Free PMC article.
-
Plant-Derived Substances with Antibacterial, Antioxidant, and Flavoring Potential to Formulate Oral Health Care Products.Biomedicines. 2021 Nov 11;9(11):1669. doi: 10.3390/biomedicines9111669. Biomedicines. 2021. PMID: 34829898 Free PMC article. Review.
References
-
- Grap M.J., Munro C.L., Unoki T., Hamilton V.A., Ward K.R. Ventilator-associated pneumonia: the potential critical role of emergency medicine in prevention. J Emerg Med. 2012;42:353–362. - PubMed
-
- Bassetti M., Taramasso L., Giacobbe D.R., Pelosi P. Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy. Expert Rev Anti Infect Ther. 2012;10:585–596. - PubMed
-
- Hillier B., Wilson C., Chamberlain D., King L. Preventing ventilator-associated pneumonia through oral care, product selection, and application method: a literature review. AACN Adv Crit Care. 2013;24:38–58. - PubMed
-
- Bickenbach J., Marx G. Diagnosis of pneumonia in mechanically ventilated patients: what is the meaning of the CPIS? Minerva Anestesiol. 2013;79:1406–1414. - PubMed
-
- Soh K.L., Shariff Ghazali S., Soh K.G., Abdul Raman R., Sharif Abdullah S.S., Ong S.L. Oral care practice for the ventilated patients in intensive care units: a pilot survey. J Infect Dev Ctries. 2012;6:333–339. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous